Translational Drug Development, LLC
Records under this name other than the patents Translational Drug Development, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 14 patents it holds.
Showing 1 to 6 of 6 · Back to Translational Drug Development, LLC
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,617,214 | Compounds for cognitive enhancement and methods of use thereof Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,236,052 | Aminobenzimidazole derivatives, treatments, and methods of inhibiting histone deacetylase Lapsed on the fee record Ended Feb 1, 2026 · From the USPTO record | Lapsed on the fee record | Ended Feb 1, 2026 | From the USPTO record |
| US 10,807,966 | Heterocyclic compounds as kinase inhibitors Lapsed on the fee record Ended Oct 20, 2024 · From the USPTO record | Lapsed on the fee record | Ended Oct 20, 2024 | From the USPTO record |
| US 9,381,196 | Compounds, pharmaceutical compositions and methods of use of hydroxamic acid derivatives Lapsed on the fee record Ended Jul 5, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jul 5, 2024 | From the USPTO record |
| US 10,584,119 | Pyrazole compounds and methods of use thereof Lapsed on the fee record Ended Mar 10, 2024 · From the USPTO record | Lapsed on the fee record | Ended Mar 10, 2024 | From the USPTO record |
| US 10,131,654 | Pyrazole compounds and methods of use thereof Lapsed on the fee record Ended Nov 20, 2022 · From the USPTO record | Lapsed on the fee record | Ended Nov 20, 2022 | From the USPTO record |